| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Wierenga Wendall is a Director at CRNX, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 10 sales. Those positions are worth an estimated $12.2M at current prices.
Our model assigns Wierenga Wendall a middling insider score of 59/100, based on 9 past trades. Over a 12-month horizon, 37.5% of those trades were profitable, with an average 12-month return of -19.3%.
Wierenga Wendall's largest disclosed position is in CRNX as Director, worth about $9.7M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | CYTK Cytokinetics Inc | Director | Sale+OE | 20,000 | $38.46 | $769,200.00 | -44.6% | -2.6% | - | |
| Dec 16, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 742 | $48.61 | $36,068.62 | -2.9% | -8.4% | +26.5% | |
| Nov 25, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 742 | $50.00 | $37,100.00 | -2.9% | -4.2% | +34.4% | |
| Oct 28, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE | 4,452 | $52.25 | $232,617.00 | -15.3% | -4.4% | +18.6% | |
| Dec 27, 2023 | CYTK Cytokinetics Inc | Director | Sale+OE | 10,000 | $73.60 | $736,000.00 | -21.1% | -14.7% | -41.8% | |
| Aug 21, 2023 | CYTK Cytokinetics Inc | Director | Sale+OE | 6,020 | $32.02 | $192,760.40 | -24.9% | -1.9% | +72.6% | |
| Feb 6, 2023 | CYTK Cytokinetics Inc | Director | Sale+OE | 7,000 | $45.00 | $315,000.00 | -35.8% | -14.3% | +78.8% | |
| Sep 1, 2022 | CYTK Cytokinetics Inc | Director | Sale+OE | 4,166 | $52.79 | $219,923.14 | -25.5% | -20.9% | -33.0% | |
| Dec 27, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 4,166 | $44.37 | $184,854.17 | -38.1% | -19.8% | -1.4% |